Results 261 to 270 of about 830,243 (383)

Supravalvular aortic stenosis

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1965
Jesse E. Edwards   +2 more
openaire   +3 more sources

Congenital Aortic Stenosis [PDF]

open access: yesCirculation, 1959
Norman J. Sissman   +3 more
openaire   +2 more sources

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan   +10 more
wiley   +1 more source

COMBINED MITRAL AND AORTIC STENOSIS [PDF]

open access: bronze, 1962
Andrew G. Morrow   +2 more
openalex   +1 more source

Aortic stenosis intricacies beyond the valve: A bidirectional Mendelian randomization study

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Numerous observational studies have reported an association between calcific aortic valve stenosis (CAVS) and an increased risk of other cardiovascular diseases (CVDs). However, the potential causal association is uncertain. Methods and results A bidirectional Mendelian randomization (MR) analysis was performed to confirm the causal ...
Dihui Cai, Jianhui Liu
wiley   +1 more source

Risk of Myocardial Infarction in Patients With Aortic Stenosis: Insights From the VALVENOR Registry. [PDF]

open access: yesJACC Adv
Lemesle G   +12 more
europepmc   +1 more source

Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy